DIMENSION THERAPEUTICS
Dimension Therapeutics is a gene therapy company focused on developing novel treatments for rare diseases. Their team comprises biotech industry veterans and thought leaders in gene therapy and rare diseases. The company is focused on advancing its platform of gene therapy programs in rare diseases through clinical development, starting with lead programs in hemophilia, and building out a world-class product engine for adeno-associated virus (AAV) therapeutics. In conjunction with its launch, ... Dimension has entered into an exclusive license and collaboration with REGENX Biosciences. REGENX holds exclusive rights to a portfolio of over 100 patents and patent applications pertaining to its NAV vector technology and related applications. Through its license and collaboration with REGENX, Dimension has acquired preferred access to NAV vector technology and rights within REGENX product programs in multiple rare disease indications. Dimension has completed a Series A financing led by Fidelity Biosciences.
DIMENSION THERAPEUTICS
Industry:
Biotechnology Genetics Medical Therapeutics
Founded:
2013-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Total Employee:
1+
Status:
Active
Contact:
617-401-0011
Email Addresses:
[email protected]
Total Funding:
124.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Domain Not Resolving IPv6 Cloudflare Google Cloud Cloudflare Hosting Cloudflare Network Error Logging Cloudflare DNS Cloudflare SSL
Similar Organizations
Corvidia
Corvidia Therapeutics focuses on the research and development of transformative therapies for cardio-renal diseases.
Fulcrum Therapeutics
Fulcrum Therapeutics is a biotechnology company that develops new medicines to treat patients with rare genetic diseases.
Juventas Therapeutics
Juventas Therapeutics is a clinical-stage biotechnology company developing regenerative therapies to treat life threatening diseases.
Neos Therapeutics
Neos Therapeutics is an oral drug delivery company developing controlled time-release technologies.
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Translate Bio
Translate Bio is a biotechnology company that specializes in biotechnology, RNA therapeutics, and rare diseases.
Semma Therapeutics
Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.
Voyager Therapeutics
Voyager Therapeutics is a gene therapy company developing treatments for fatal and debilitating diseases of the central nervous system
Larimar Therapeutics
Larimar Therapeutics is a clinical-stage biotechnology company focused on developing treatments for complex rare diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
RA Capital Management
RA Capital Management investment in Series B - Dimension Therapeutics
Jennison Associates
Jennison Associates investment in Series B - Dimension Therapeutics
New Leaf Venture Partners
New Leaf Venture Partners investment in Series B - Dimension Therapeutics
Rock Springs Capital
Rock Springs Capital investment in Series B - Dimension Therapeutics
Partner Fund Management
Partner Fund Management investment in Series B - Dimension Therapeutics
Tourbillon Global Ventures
Tourbillon Global Ventures investment in Series B - Dimension Therapeutics
F-Prime Capital
F-Prime Capital investment in Series B - Dimension Therapeutics
OrbiMed
OrbiMed investment in Series B - Dimension Therapeutics
Fidelity Biosciences
Fidelity Biosciences investment in Series A - Dimension Therapeutics
OrbiMed
OrbiMed investment in Series A - Dimension Therapeutics